Clinical Trials Market: Global Industry Analysis and Forecast (2023 -2029) Trends, Statistics, Dynamics, Segmentation by Type, Phase, Service Type, Therapy Area, Application and Region

Clinical Trials Market size was valued at USD 48.7 Bn in 2022 and the total Clinical Trials revenue is expected to grow by 6.1% from 2023 to 2029, reaching nearly USD 78.3 Bn.

Clinical Trials Market Overview:

The clinical trials market covers all the testing procedures conducted on a product prior to the approval in the market. The clinical trials market report will provide deep insights on the market dynamics for clinical trials & changing dynamics during the forecast period. The clinical trials market analysis by clinical trail phase & region will facilitate the industry The pharmaceutical industry is emphasizing on research & development for developing innovative products. Companies fail to achieve the compliance for the products multiple times before the product is launched into the clinical trials market. This is resulting in companies requiring more no of clinical trials. Many players in the clinical trials market are outsourcing clinical trials to save their time & cost. The CROs are updating their technology to facilitate all types of clinical trials driving the market growth. Clinical Trials MarketTo know about the Research Methodology :- Request Free Sample Report

Clinical Trials Market Dynamics:

Competitive Landscape: The Clinical trials market is witnessing a stiff competition among the leading players. The adoption of advanced technology is the main area of competition in the clinical trials market. Players having updated technology for conducting specialised clinical trials are having an competitive edge. Mergers & acquisitions & new product launches by the key players are enabling them to retain their share in the clinical trials market. For Instance, In April 2021, clinical end point data solutions provider ERT announced merger with Bioclinica a leader in clinical imaging. The merger helped the company to expand their business portfolio. In November 2021, the combined company was named Clario. Clinical Trials Market Drivers Increasing no of clinical trials The no of clinical trails conducted are rising exponentially driving the clinical trials market. The focus on patient safety is increasing the requirement for clinical trials. The stringent requirements for approval resulting companies having a requirement of multiple clinical trails to approve the product. As of June 2021, Europe & North America accounted for the highest no of clinical trials. The United States have registered more than 30% of clinical trials as of Jan 2023. The decentralised clinical trials recorded a 25% increase in 2022. The decentralization of clinical trials have increased the momentum for clinical trials market. Growing Disease Burden The prevalence of chronic disorders across the world is high. The chronic disorders account for 74% of the death globally. In the U.S. 125 million citizens have chronic disorder. The growth of infectious diseases is also alarming with 71.8 per 10,000 population have an infectious disease currently. The huge disease burden is resulting in huge demand for new drugs. The higher demand of mew drugs is resulting in high demand for quick & effective clinical trials driving the clinical trials market growth. Majority of the new molecules are dedicate to cancer therapy. In 2021, the prevalence of cancer is 450 cases of cancer per 10,000 population. The mortality from cancer is higher in men with 190 deaths per 10,000 men. Cancer being a leading cause of mortality globally, is a point of attention for pharmaceutical industry. The new cancer drugs require detailed clinical trials. This is expected to have positive impact on the clinical trials market during the forecast period.

Clinical Trials Market Segment Analysis:

Based on Phase On the basis of Phase, the clinical trials market is segmented into phase I, II, III & IV. Phase III dominated the market in 2021. Phase III trials are highly expensive & involve large subjects. The average cost of clinical trail is 19.0 million. Companies receive approvals post phase III trials making it a crucial phase in clinical trials. Phase IV trials are expected to witness fastest growth in the clinical trials market during the forecast period. Duration of therapy, dose, variety of formulations & other interaction are studied in this phase as post marketing surveillance. The increase in no of service providers providing post marketing surveillance is driving the segment growth. Based on the Service Type Based on the service type, laboratory services segment accounted for the highest growth in the clinical trials market. Laboratory services are adopted during all phases of clinical trials. The quality & efficacy of products is determined through various qualitative & quantitative testing requiring laboratory services. The Clinical trials logistic & supply services are expected to witness significant growth in the clinical trials market during the forecast period. The supply for volunteers & logistic management is crucial for clinical trials. The increase in the amount of clinical trials is driving the need for these services. Clinical Trials Market1Based on the Therapy Based on the therapy type, the clinical trials market is segmented into cardiology, oncology, infectious diseases, women’s health, immunology, neurology & others. Oncology segment has the highest market share in 2021. The increase in development for new cancer drugs in response to the rising prevalence. The cardiology segment is expected to witness significant growth in the clinical trials market during the forecast period. Cardiac disorders are the leading cause of mortality worldwide as of 2021. The sedimentary lifestyle is expected to further increase the risk of cardiac disorders. The companies are investing a lot in the cardiac segment, driving the segment growth during the forecast period Clinical Trials Market2Based on the Application Based on the application the market is segmented into application, vaccines, cell & gene therapy and others. The vaccine segment has the highest market share in 2021. Companies are developing vaccines for various infectious diseases, especially COVID-19. The gene therapy segment is expected to have significant growth during the forecast period. The companies are trying to target the genetic disorder patients. Lot of genetic disorders patients are looking solutions enabling them to live a better quality of life. This is expected to drive the market growth.

Clinical Trials Market3Clinical Trials Market Regional Insights:

By region, the Clinical trials market segmented into North America, Europe, Asia Pacific, Middle East Africa & Latin America. North America region. North America region is dominated the clinical trials market in 2021. The high investment on research & development in the region is driving the market growth. The availability of better infrastructure for clinical testing in the region is expected to drive the Clinical trials market growth in the region. Asia Pacific region is estimated to have the fastest growth during the forecast period. This can be attributed to the presence & interest of key players like Novartis Ag, AstraZeneca, GSK and others in the region. The companies are conducting campaigns for undetected patients & spreading awareness. This is resulting in higher no of cases detected & treated driving the segment growth.

Clinical Trials Market Scope: Inquire before buying

Clinical Trials Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2017 to 2022 Market Size in 2022: US $ 48.7 Bn.
Forecast Period 2023 to 2029 CAGR: 6.1% Market Size in 2029: US $ 78.3 Bn.
Segments Covered: by Phase 1.Phase I 2.Phase II 3.Phase III 4.Phase IV
by Service Type 1.Protocol Designing 2.Site Identification 3.Patient Recruitment 4.Laboratory Services 5.Bioanalytical Testing Services 6.Analytical Testing Services 7.Clinical Trials Supply & Logistic Services 8.Decentralized Clinical Services 9.Clinical Trial Management Services 10.Medical Device Testing Services 11.Other clinical trial services
by Therapy 1.Oncology 2.Infectious Diseases 3.Cardiology 4.Neurology 5.Women’s Health 6.Genetic Diseases 7.Immunology 8.Other Therapy Area’s
by Application 1.Vaccine 2.Cell & Gene Therapy 3.Small Molecules 4.Other Applications

Clinical Trials Market, by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Clinical Trials Market Key Players

1.IQVIA 2.Clario 3. Clinipace 4.aboratory Corporation of America 5. Eli Lilly and Company 6.ICON PLC 7.Novo Nordisk AS 8.PAREXEL International Corporation 9.Pfizer Inc. 10.Pharmaceutical Product Development LLC 11. Hoffmann-La Roche Ltd 12. Sanofi SA 13.Syneos Health 14.ClinDatrix Inc 15.Charles River Laborator Frequently Asked Questions: 1] What segments are covered in the Global Clinical trials Market report? Ans. The segments covered in the Clinical trials Market report are based on phase, service type, therapy type and application and Region. 2] Which region is expected to hold the highest share in the Global Clinical trials Market? Ans. The North America region is expected to hold the highest share of the Clinical Trials Market. 3] What is the market size of the Clinical Trials Market by 2029? Ans. The market size of the Clinical Trials Market by 2029 is expected to reach US$ 78.3 Bn. 4] What is the forecast period for the Global Clinical Trials Market? Ans. The forecast period for the Clinical trials Market is 2023-2029. 5] What was the market size of the Clinical Trials Market in 2021? Ans. The market size of the Clinical Trials Market in 2021 was valued at US$ 48.7 Bn.
1.Clinical Trials Market: Research Methodology 2. Clinical Trials Market: Executive Summary 3. Clinical Trials Market: Competitive Landscape • MMR Competition Matrix • Competitive Landscape • Key Players Benchmarking • Global Market Key Player Ranking Analysis • Market Structure o Market Leaders o Market Followers o Emerging Players • Consolidation of the Market 4. Clinical Trials Market: Dynamics • Market Trends by region • North America • Europe • Asia Pacific • Middle East and Africa • South America • Market Drivers by Region • North America • Europe • Asia Pacific • Middle East and Africa • South America • Market Restraints • Market Opportunities • Market Challenges • PORTER’s Five Forces Analysis • PESTLE • Value Chain Analysis • Regulatory Landscape by Region • North America • Europe • Asia Pacific • Middle East and Africa • South America • COVID-19 Impact on the Market 5. Global Clinical Trials Market: Segmentation (by Value and Volume) • Global Clinical Trials Market, by Phase (2022-2029) • Phase I • Phase II • Phase III • Phase IV • Global Clinical Trials Market, by Service Type (2022-2029) • Protocol Designing • Site Identification • Patient Recruitment • Laboratory Services • Bioanalytical Testing Services • Analytical Testing Services • Clinical Trials Supply & Logistic Services • Decentralized Clinical Services • Clinical Trial Management Services • Medical Device Testing Services • Other clinical trial services • Global Clinical Trials Market, by Therapy Type (2022-2029) • Oncology • Infectious Diseases • Cardiology • Neurology • Women’s Health • Genetic Diseases • Immunology • Other Therapy Area’s • Global Clinical Trials Market, by Application (2022-2029) • Vaccine • Cell & Gene Therapy • Small Molecules • Other Applications 6. North America Clinical Trials Market (by Value and Volume) • North America Clinical Trials Market, by Phase (2022-2029) • Phase I • Phase II • Phase III • Phase IV • North America Clinical Trials Market, by Service Type (2022-2029) • Protocol Designing • Site Identification • Patient Recruitment • Laboratory Services • Bioanalytical Testing Services • Analytical Testing Services • Clinical Trials Supply & Logistic Services • Decentralized Clinical Services • Clinical Trial Management Services • Medical Device Testing Services • Other clinical trial services • North America Clinical Trials Market, by Therapy Type (2022-2029) • Oncology • Infectious Diseases • Cardiology • Neurology • Women’s Health • Genetic Diseases • Immunology • Other Therapy Area’s • North America Clinical Trials Market, by Application (2022-2029) • Vaccine • Cell & Gene Therapy • Small Molecules • Other Applications 7. Europe Clinical Trials Market (by Value and Volume) • Europe Clinical Trials Market, by Phase (2022-2029) • Europe Clinical Trials Market, by Service Type (2022-2029) • Europe Clinical Trials Market, by Therapy Type (2022-2029) • Europe Clinical Trials Market, by Application (2022-2029) • Europe Clinical Trials Market, by Country (2022-2029) • France • Germany • Italy • Spain • Sweden • Austria • Rest of Europe 8. Asia Pacific Clinical Trials Market (by Value and Volume) • Asia Pacific Clinical Trials Market, by Phase (2022-2029) • Asia Pacific Clinical Trials Market, by Service Type (2022-2029) • Asia Pacific Clinical Trials Market, by Therapy Type (2022-2029) • Asia Pacific Clinical Trials Market, by Application (2022-2029) • Asia Pacific Clinical Trials Market, by Country (2022-2029) • Japan • India • Australia • Indonesia • Malaysia • Vietnam • Taiwan • Bangladesh • Pakistan • Other Asia Pacific 9. Middle East and Africa Clinical Trials Market (by Value and Volume) • Middle East and Africa Clinical Trials Market, by Phase (2022-2029) • Middle East and Africa Clinical Trials Market, by Service Type (2022-2029) • Middle East and Africa Clinical Trials Market, by Therapy Type (2022-2029) • Middle East and Africa Clinical Trials Market, by Application (2022-2029) • Middle East and Africa Clinical Trials Market, by Country (2022-2029) • South Africa • GCC • Egypt • Nigeria • Rest of ME&A 10. South America Clinical Trials Market (by Value and Volume) • South America Clinical Trials Market, by Phase (2022-2029) • South America Clinical Trials Market, by Service Type (2022-2029) • South America Clinical Trials Market, by Therapy Type (2022-2029) • South America Clinical Trials Market, by Application (2022-2029) • South America Clinical Trials Market, by Country (2022-2029)) 11. Company Profile: Key players • IQVIA • Company Overview • Financial Overview • Business Portfolio • SWOT Analysis • Business Strategy • Recent Developments • Clario • Clinipace • aboratory Corporation of America • Eli Lilly and Company • ICON PLC • Novo Nordisk AS • PAREXEL International Corporation • Pfizer Inc. • Pharmaceutical Product Development LLC • Hoffmann-La Roche Ltd • Sanofi SA • Syneos Health • ClinDatrix Inc • Charles River Laborator 12. Key Findings 13. Industry Recommendation

About This Report

Report ID 189646
Category Healthcare
Published Date May 2023
Updated Date
  • INQUIRE BEFORE BUYING